Histone deacetylase inhibitors sensitize glioblastoma models to temozolomide and reprogram immunosuppressive myeloid cells

G Golnaz Asaadi Tehrani R Rebecca N. Kubick M Maksym Zarodniuk (Department of Aerospace and Mechanical Engineering, University of Notre Dame) M Meenal Datta (Department of Radiation Oncology, Edwin L. Steele Laboratories, Massachusetts General Hospital and Harvard Medical School)

Article Details

Volume / Issue Vol. 15, Issue 1
Published October 21, 2025
ISSN 2045-2322
Publisher Nature Portfolio

Journal Info

Scientific Reports

Nature Portfolio

ISSN: 2045-2322 Open Access Life Sciences

Authors (4)

G

Golnaz Asaadi Tehrani

R

Rebecca N. Kubick

M

Maksym Zarodniuk

Department of Aerospace and Mechanical Engineering, University of Notre Dame

M

Meenal Datta

Department of Radiation Oncology, Edwin L. Steele Laboratories, Massachusetts General Hospital and Harvard Medical School